期刊文献+

血浆脑钠肽在非ST段抬高急性冠状动脉综合征危险分层中的临床意义 被引量:3

The clinical value of N-terminal natriuretic peptide in risk stratification for the patients with non-ST elevation acute coronary syndrome
原文传递
导出
摘要 目的:探讨非ST段抬高急性冠状动脉综合征(NSTE-ACS)患者血中N末端脑钠肽(NT-BNP)水平在危险分层中的意义。方法:入选81例患者,入院检查NT-BNP及肌钙蛋白I浓度(cTnI),依据GRACE评分标准对患者进行风险评估,计算积分,并进行危险分层,分为低危、中危、高危3组。分析NT-BNP与cTnI浓度及GRACE积分的关系;对比不同组别患者NT-BNP水平的差异。结果:NSTE-ACS患者NT-BNP与cTnI及GRACE积分呈正相关,并且低危、中危及高危组之间NT-BNP浓度有显著性差异(P<0.05)。结论:NSTE-ACS患者NT-BNP水平越高,GRACE积分越高,NT-BNP的检测对NSTE-ACS患者进行早期、快速的危险度分层方面有着独特的价值。 Objective:To explore the clinical value of N-terminal natriuretic peptide (NT-BNP) in risk stratifi- cation for patients with non-ST elevation acute coronary syndrome (NSTE-ACS). Method: We enrolled 81 pa- tients with NSTE-ACS. In these patients, NT-BNP and cardiac troponin I (cTnI) concentration were tested. According to the GRACE score standard, all patients were stratified into threee groups. The relationship between NT-BNP level and GRACE risk score as welt as cTn I was analyzed. The difference of NT-BNP in three groups was compared. Result:The relationship between NT-BNP level and GRACE score as well as cTnI were positively correlated. The NT-BNP levels in three groups had significant differences (P^0.05). Conclusion: In patients with NSTE-ACS, the higher NT-BNP concentration, the higher the GRACE scoreis, Measurement of NT-BNP is valuable for risk stratification in patients with NSTE-ACS.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2015年第5期539-540,共2页 Journal of Clinical Cardiology
关键词 N端脑钠肽 非ST段抬高急性冠脉综合征 GRACE评分 N-terminal brain natriuretic peptide acute coronary syndrome GRACE score
  • 相关文献

参考文献8

  • 1无,沈卫峰,胡大一.非ST段抬高急性冠状动脉综合征诊断和治疗指南[J].中华心血管病杂志,2012,40(5):353-367. 被引量:679
  • 2CHOI E Y, KWON H M, YOON Y W, et al. As- sessment of extent of myocardial ischemia in patients with non-ST elevtion acute coronary syndrome using serum B-type natruretic peptide level [J]. Yonsei Med J, 2004,45:255-262.
  • 3GOYAL B M, SHARMA S M, WALIA M. B-type natriuretic peptide levels pridict extent and severity of coronary artery disease in non-ST elevation acute cor- onary syndrome and normal left ventricular function [J]. Indian Heart J,2014,66:183-187.
  • 4WIDERA C, PENCINA M J, MEISNER A, et al. Adjustment of the GRACE score by growth differenti- ation factor 15 enables a more accurate appreciation of risk in non-ST elevation acute coronary syndrome [J]. Eur Heart J, 2012,33.. 1095--1104.
  • 5TAKADA J Y, RAMOS R B, AVAKIAN S D, et al. BNP and admission glucose as in-hospital mortality predictors in non-ST elevation myocardial infarction [J]. Scient World J, 2012:397915.
  • 6ZDRAVKOVIC V, MLADENOVIC V, COLIC M, et al. NT-proBNP for NT-prognostic and diagnostic e- valuation in patients with acute coronary syndromes [J]. Kardiol Pol, 2013,71(5) :472--479.
  • 7苏华,周胜华,潘宏伟,杜优优,刘彬,刘厂辉.脑钠肽对不稳定型心绞痛和(或)非ST段抬高心肌梗死患者冠状动脉病变程度的预测[J].临床心血管病杂志,2008,24(2):117-119. 被引量:26
  • 8赵晗,刘文娴.非ST段抬高急性冠状动脉综合征患者血浆NT-ProBNP与GRACE危险分层的关系[J].心肺血管病杂志,2011,30(2):111-115. 被引量:15

二级参考文献25

共引文献716

同被引文献18

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部